Free Shipping on Order Over $60
AfterPay Available
Gene Therapy of Cancer

Gene Therapy of Cancer

Translational Approaches from Preclinical Studies to Clinical Implementation

by Stanton L. Gerson and Edmund C. Lattime
Hardback
Publication Date: 20/09/2013
22%
OFF
RRP  $235.95 $186.35
or 4 easy payments of $46.59 with
afterpay
      Please Note: We will source your item through a special order. Generally sent within 120 days.
This item qualifies for FREE delivery
Gene therapy as a treatment for cancer is at a critical point in its evolution. Exciting new developments in gene targeting and vector technology, coupled with results from the first generation of preclinical and clinical studies have led to the design and testing of new therapeutic approaches. The Third Edition of Gene Therapy of Cancer provides crucial updates on the basic and applied sciences of gene therapy. It offers a comprehensive assessment of the field including the areas of suicide gene therapy, oncogene and suppressor gene targeting, immunotherapy, drug resistance gene therapy, and the genetic modification of stem cells. Researchers at all levels of development, from basic laboratory investigators to clinical practitioners, will find this book to be instructive.

Cancer gene therapy, like cancer therapy in general, is evolving rapidly, testing new concepts, targets and pathways, evoking new technologies, and passing new regulatory hurdles. Its essence, however, has not changed: the hope and challenges of returning altered genes to normal, using targeted gene expression to alter the function of both tumor and microenvironment, and in some cases normal cells, and delivering functionally important genes to specific cell types to increase sensitivity to killing or to protect normal cells from cancer therapies.

In some instances, gene therapy for cancer forms a continuum from gene repair through the use of molecularly modified cells; the use of viral and non-viral vector based gene delivery to both tumor and tumor microenvironment; the use of viral and gene based vaccines; and development of new gene-based therapeutics. The unique mechanistically chosen vector platforms are at the heart of this technology because they allow for direct and selective cell death and transient to sustained delivery of vaccine molecules or molecules that affect the microenvironment, vasculature, or the immune response.
ISBN:
9780123942951
9780123942951
Category:
Oncology
Format:
Hardback
Publication Date:
20-09-2013
Language:
English
Publisher:
Elsevier Science Publishing Co Inc
Country of origin:
United States
Edition:
3rd Edition
Pages:
554
Dimensions (mm):
276x216x30mm
Weight:
1.86kg

Our Australian supplier has this title on order.  You can place a backorder for this title now and we will ship it to you when it becomes available. 

While we are unable to provide a delivery estimate, most backorders will be delivered within 120 days. If we are informed by our supplier that the title is no longer available during this time, we will cancel and refund you for this item.  Likewise, if no delivery estimate has been provided within 120 days, we will contact our supplier for an update.  If there is still no delivery estimate we will then cancel the item and provided you with a refund.

If we are able to secure you a copy of the title, our supplier will despatch it to our Sydney warehouse.  Once received we make sure it is in perfect condition and then despatch it to you via the Australia Post eParcel service, which includes online tracking.  You will receive a shipping notice from us when this occurs.

Customer Reviews

Be the first to review Gene Therapy of Cancer.